Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.1256 per EA under NDC 42858020201. Its NADAC has been published 549 times since May 18, 2016.

FDA first approved this application on Apr 12, 2016. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1256per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

NDC

42858020201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202991

FDA Approved

4/12/2016

TE Code

AA

On Market Since

4/12/2016

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 549 times since May 18, 2016, and over the history we have for it it has declined 39.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1256 per EA
All-time high$0.2085 (Sep 14, 2016)
All-time low$0.0932 (Dec 18, 2019)
52-week high$0.1485
52-week low$0.1256
Median price$0.1361
Average price$0.1390
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked549
Tracking sinceMay 18, 2016

Price History

1W

-3.8%

1M

-7.2%

3M

-9.1%

6M

-9.0%

1Y

-16.3%

3Y

-0.8%

5Y

+13.1%

All

-39.1%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.1256 per EA (NDC 42858020201), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 39.1%. It has been tracked across 549 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since May 18, 2016, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.2085 (Sep 14, 2016), with a median of $0.1361 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 42858020201) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.